SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-136851
Filing Date
2013-04-01
Accepted
2013-04-01 17:05:21
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d511759d10qa.htm 10-Q/A 584495
2 EX-31.1 d511759dex311.htm EX-31.1 8071
3 EX-31.2 d511759dex312.htm EX-31.2 8090
4 EX-32.1 d511759dex321.htm EX-32.1 4015
5 EX-32.2 d511759dex322.htm EX-32.2 4074
  Complete submission text file 0001193125-13-136851.txt   3720050

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scln-20120331.xml EX-101.INS 723825
7 XBRL TAXONOMY EXTENSION SCHEMA scln-20120331.xsd EX-101.SCH 14892
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scln-20120331_cal.xml EX-101.CAL 36806
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE scln-20120331_lab.xml EX-101.LAB 125358
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scln-20120331_pre.xml EX-101.PRE 76447
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19825 | Film No.: 13732117
SIC: 2834 Pharmaceutical Preparations